3rd Quarter - Report — PATIENTS RISING NOW for PATIENTS RISING NOW (2023)

Firm

PATIENTS RISING NOW

Client

PATIENTS RISING NOW

Income

—

Expenses

$30,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Transparency. Copay Accumulators/Maximizers. Benefit Design. Quality-Adjusted Life Years. Essential Health Benefits. Strategic Enforcement Plan for 2024. H.R.485 - Protecting Health Care for All Patients Act. H.R.830 - HELP Copays Act. H.R.1092/S.526 - BENEFIT Act. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023. H.R.2630/S.652 - Safe Step Act. H.R.2408 - Access to Innovative Treatments Act of 2023.

Lobbyist	Covered position, as disclosed
DAVIS MCRAE WALL HAGIGH	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Equal Employment Opportunity Commission (EEOC); SENATE

Bills named: H.R. 1092 (118th), H.R. 830 (118th), H.R. 2408 (118th), S. 526 (118th), H.R. 1613 (118th), H.R. 485 (118th), H.R. 2630 (118th), S. 652 (118th)

Pharmacy PHA

Accelerated Approval. Pharmacy Benefits Managers. S.127 - Pharmacy Benefit Manager Transparency Act of 2023. Medical patents. Alternative Funding Vendors. H.R.2816 - PBM Sunshine and Accountability Act. H.R.2880 - Protecting Patients from PBM Abuses Act. H.R.3839 - Increasing Transparency in Generic Drug Applications Act.

Lobbyist	Covered position, as disclosed
DAVIS MCRAE WALL HAGIGH	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 127 (118th), H.R. 2816 (118th), H.R. 2880 (118th), H.R. 3839 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.